Please login to the form below

Not currently logged in
Email:
Password:

Sanofi appoints Diane Souza and Thomas Südhof

They join the board as independent directors

Sanofi has appointed Diane Souza and Thomas Südhof to its board of directors as independent directors, effective 4 May.

Souza brings over 25 years of managed care and health benefits expertise as well as financial management experience to the board. She most recently served as chief executive officer of UnitedHealthcare Speciality Benefits, a voluntary health insurance business.

Prior to this, Souza held the role of chief financial officer at Aetna, overseeing its guaranteed products business, and has also held senior leadership positions at Deloitte and PriceWaterhouseCooper.

Meanwhile, Südhof currently serves as the Avram Goldstein professor and professor of molecular and cellular physiology, psychiatry and neurology at Stanford University's school of medicine.

Before joining Stanford, he spent 25 years at the University of Texas as chairman of the department of neuroscience researching neuro-degenerative and neuro-psychiatric diseases. Südhof was a member of team who won the Nobel Prize in physiology or medicine in 2013.

Serge Weinberg, chairman of Sanofi's board, said: “Both Diane Souza and Thomas Südhof are noted health experts and their great skills make them an outstanding addition to our board.

“We look forward to their contribution to Sanofi's strategy as we continue to innovate and introduce new medicines and vaccines that can help improve health outcomes.”

22nd March 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Havas Lynx Group

We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics